AZ-ETHISPHERE
15.3.2022 11:02:14 CET | Business Wire | Press release
Ethisphere, a global leader in defining and advancing the standards of ethical business practices, today announced the 136 honorees representing 22 countries and 45 industries that have earned the coveted designation of World’s Most Ethical Companies® in 2022 .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220315005079/en/
This is the 16th annual recognition of companies that have demonstrated a commitment to ethical business practices through programs that positively impact employees, communities, and broader stakeholders, and contribute to sustainable and profitable long-term business performance.
In 2022, 14 companies are first-time honorees, while six have been recognized 16 times – every year since the inception of the awards in 2007.
“The moment is now, and the data is clear – companies must lead on sustainability, social issues, and governance. The World’s Most Ethical Companies understand that the capitalism of today and tomorrow is one that demonstrates how we turn our ideals into action,” said Ethisphere CEO, Timothy Erblich . “Congratulations to the 2022 honorees for their dedication to advancing business integrity, for leadership on tough issues, and demonstrating that doing good is key to successful, long-term performance.”
“At TIAA, transparency, accountability, and integrity are values deeply embedded in our culture,” said Thasunda Brown Duckett, President and CEO of TIAA . “We know our clients want to work with a partner they trust, and we work hard to do right by them, our employees, and our communities. We’re honored to be named one of the World’s Most Ethical Companies by Ethisphere for the eighth straight year.”
“Recognition for the 14th time as one of the World’s Most Ethical Companies is an incredible honor for which we credit our 400,000 green apron partners (employees) who show up with a common mission,” said Kevin Johnson, president and ceo, Starbucks Coffee Company. “At Starbucks, we know we have to earn the trust we have from our partners, customers, and communities each day by leading with a purpose that goes well beyond the pursuit of profit.”
“It’s a true honor to be named as one of the World’s Most Ethical Companies for the 9th consecutive year,” said Steve James, CEO of Teachers Mutual Bank Limited . “As one of only five banks across the globe to be honored this year, this recognition reinforces our credentials as a socially responsible bank seeking to make a difference. I’m proud to lead a company that is using banking as a force for good.”
Ethisphere’s 2022 Ethics Index, the collection of publicly traded companies recognized as recipients of this year’s World’s Most Ethical Companies designation, outperformed a comparable index of large-cap companies by 24.6 percentage points over the past five calendar years.
“The outperformance, which Ethisphere refers to as the Ethics Premium , has remained consistent since we began tracking the equity performance of honoree companies. We believe this outperformance is the result of the kinds of practices that lead a company to be on our list – practices that demonstrate investment in their people, culture, and communities. We see in this data that those practices, over time, lead to stronger financial performance,” Erblich added.
Ethisphere will host a Virtual Honoree Gala on April 12, 2022. It will feature keynote addresses by Matthew McConaughey, Academy Award® –winning actor, New York Times bestselling author, and founder of the just keep livin Foundation ; and Ernie Johnson , six-time Sports Emmy Award winner, and New York Times bestselling author of Unscripted: The Unpredictable Moments that Make Life Extraordinary .
Methodology & Outcomes
Grounded in Ethisphere’s proprietary Ethics Quotient® , the World’s Most Ethical Companies assessment process includes more than 200 data points on culture; environmental and social practices; ethics and compliance activities; governance; diversity, equity, and inclusion; and initiatives that support a strong value chain. The process serves as an operating framework to capture and codify the leading practices of organizations across industries and around the globe.
This year, the evaluation was updated to include questions inquiring about programmatic changes made in response to the continuing COVID-19 pandemic. It also included a new area around risk assessment, to better address the U.S. Department of Justice’s recent focus on effectiveness of a company’s risk assessment efforts; more detailed questions around key impact assessment processes; and a range of other updates to reflect the evolving landscape as it relates to those in ethics, compliance, and governance.
All companies that participate in the assessment process receive an Analytical Scorecard that provides insights into key trends among honoree companies, and where their programs stand compared to the class of honoree companies. Applicants also receive a three-month Associate membership to the Business Ethics Leadership Alliance (BELA).
Honorees
The full list of the 2022 World’s Most Ethical Companies can be found at https://worldsmostethicalcompanies.com/honorees/ .
Follow the conversation on Twitter: 2022 #WorldsMostEthicalCompanies.
About Ethisphere
Ethisphere® is the global leader in defining and advancing the standards of ethical business practices that fuel corporate character, marketplace trust, and business success. Ethisphere has deep expertise in measuring and defining core ethics standards using data-driven insights that help companies enhance corporate character and measure and improve culture. Ethisphere honors superior achievement through its World’s Most Ethical Companies recognition program and provides a community of industry experts with the Business Ethics Leadership Alliance (BELA). https://ethisphere.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220315005079/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
KATE Launches "KABUKE: Break Convention" Kabuki-Inspired International Campaign17.7.2026 09:00:00 CEST | Press release
Where “NO MORE RULES.” intersects with the Kabuku spirit. Inspired by Japanese aesthetics, KATE shares the value of shadow enhancing makeup and self‑expression with the world. Global cosmetics brand KATE launched “KABUKE: Break Convention,” a new international campaign drawing on elements of Kabuki, the traditional Japanese performing art. The campaign debuted on Wednesday, July 8, 2026. In this campaign, KATE’s shadow enhancing makeup—rooted in Japanese aesthetics—was paired with the Kabuki spirit inherited from traditional Kabuki theater to communicate the value of individuality and self‑expression through makeup on a global scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708829427/en/ KATE international campaign “KABUKE: Break Convention” key visual. Dedicated website: https://www.kate-global.net/my/special/kate_kabuki/ Since its founding, KATE has championed the slogan “NO MORE RULES.,” offering makeup that defi
Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe’s Coverage of ESCMID Global Congress 202617.7.2026 03:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that results from the global Phase III trial (Integral-2) of nacubactam (Development Code: OP0595), a novel β-lactamase inhibitor, were highlighted in The Lancet Microbe’s coverage of ESCMID Global Congress 2026 (held in Munich, Germany). As highlighted in The Lancet Microbe’s coverage, the key findings presented by Meiji Seika Pharma at ESCMID Global Congress 2026 are as follows: The Integral-2 study (jRCT2031230076) is a global Phase III clinical trial that enrolled patients with complicated urinary tract infections, acute uncomplicated pyelonephritis, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, or complicated intra-abdominal infections caused by carbapenem-resistant Gram-negative bacteria (excluding Acinetobacter species). The study has achieved the prespecified study objectives. For the primary endpoint of overall treatme
Yoshihiro Shimamura Joins the Marché du Film’s “Investors Circle 2026” as an Invited Investor, Backing a New Feature Film17.7.2026 03:00:00 CEST | Press release
Shimamura Yoshihiro Film Production Co., Ltd. (Head office: Osaka, Japan; Representative Director: Yoshihiro Shimamura), a company active in film production and investment, today announced that Representative Director Yoshihiro Shimamura has decided to invest in an international feature film after being invited to the “Investors Circle 2026” — a distinction that reflects his standing as one of the field’s most highly regarded producers and investors. Hosted by the Marché du Film, the business arm of the Festival de Cannes and one of the world’s largest film markets, the Investors Circle is an invitation-only summit that connects a select group of private investors with high-end feature films during early-stage financing. Held in Cannes, France, May 16-17, 2026, it brings internationally acclaimed directors and producers together with investors around a curated slate of projects in development. During the summit, Shimamura attended private pitching sessions and, after individual meeting
Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies17.7.2026 00:00:00 CEST | Press release
On average, about 75% of patients with scalp psoriasis treated with zasocitinib achieved clear or almost clear skin at week 16 Approximately 70% of patients with palmoplantar disease treated with zasocitinib achieved clear or almost clear skin at week 16 Zasocitinib demonstrated statistically significant improvements in Nail Psoriasis Severity Index (NAPSI) versus placebo Results reinforce the potential of zasocitinib to deliver rapid and durable skin clearance, including in the hardest-to-treat areas, in a convenient once-daily pill Takeda (TSE:4502/NYSE:TAK) announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented at the 2026 American Academy of Dermatology (AAD) Innovation Academy, these secondary endpoint data show that zasocitinib demonstrated consistent and high rates of skin clearance across hard-to-
Merz Completes Inaugural €450 Million Schuldschein Loan Issuance16.7.2026 23:36:00 CEST | Press release
Debut transaction more than three times oversubscribed The Merz Group has successfully completed its first-ever Schuldschein loan issuance, placing a total volume of €450 million in the debt capital market – a multiple of three relating to the launch volume. The debut transaction was significantly oversubscribed and attracted strong interest from all investor groups. The proceeds were settled and paid out today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716926041/en/ Dr. Almuth Steinkühler, Chief Financial Officer Merz Group The transaction comprises both fixed- and floating-rate tranches with maturities of three, five, seven, and ten years. Around 50 German and international investors participated, representing a broad range of institutions, including private banks, German federal state-owned banks, public savings banks, cooperative banks, pension funds and occupational pension institutions. With the successful plac
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
